Publications by authors named "Mark D Vincent"

Claim this Profile
C
Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC.
Barbara Melosky, Quincy S C Chu, Rosalyn A Juergens, Stephanie Snow, Normand Blais, Mark D Vincent

Lung Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non-small cell lung cancer.
Barbara Melosky, Mark D Vincent, Anna L McGuire, Anthony M Brade, Quincy Chu

Int J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada.
Winson Y Cheung, Setareh Samimi, Kim Ma, Gregory John Knight, Shaqil Kassam, Mark David Vincent

Clin Colorectal Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel Mutation to Neoadjuvant Pembrolizumab.
Beatrice Preti, Laila Schenkel, Matthew Cecchini, Tommaso Romagnoli, Michael Susmoy Sanatani, Mark David Vincent

Curr Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Analysis of Durvalumab after Chemoradiation in Stage III Non-Small-Cell Lung Cancer.
Beatrice T B Preti, Michael S Sanatani, Daniel Breadner, Suganija Lakkunarajah, Carolyn Scott, Mark D Vincent

Curr Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled Trial.
Brian P Yaremko, Dante P I Capaldi, Khadija Sheikh, David A Palma, Andrew Warner, Mark D Vincent

Int J Radiat Oncol Biol Phys· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial.
Richard A Malthaner, Edward Yu, Michael Sanatani, Debra Lewis, Andrew Warner, Mark D Vincent

Thorac Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.
Edward Yu, Alison L Allan, Michael Sanatani, Debra Lewis, Andrew Warner, Mark D Vincent

BMC Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study.
Daniel A Breadner, Mark D Vincent, Rohann Correa, Morgan Black, Andrew Warner

Lung Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin Deep: A Fascinating Case Report of Immunotherapy-Triggered, Treatment-Refractory Autoimmune Lichen Planus and Keratoacanthoma.
Beatrice T B Preti, Alec Pencz, Jeffery J M Cowger, Mark D Vincent, Daniel Breadner

Case Rep Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis.
Jacques Raphael, Anupam Batra, Gabriel Boldt, Prakesh S Shah, Phillip Blanchette, Mark D Vincent

Clin Lung Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health related quality of life in older or frail patients with advanced colorectal cancer treated with dose reduced capecitabine.
Daniel Breadner, Mark David Vincent, Derek Jonker, Christine Cripps, Paul Klimo

J Geriatr Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness vs. affordability in the age of immuno-oncology cancer drugs.
George Dranitsaris, Xiaofu Zhu, Georges Adunlin, Mark D Vincent

Expert Rev Pharmacoecon Outcomes Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype.
Stefan Rodic, Mark David Vincent

Int J Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic Antiproliferative Activity of the RAD51 Inhibitor IBR2 with Inhibitors of Receptor Tyrosine Kinases and Microtubule Protein.
Peter J Ferguson, Mark D Vincent, James Koropatnick

J Pharmacol Exp Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer: Towards a general theory of the target: All successful cancer therapies, actual or potential, are reducible to either (or both) of two fundamental strategies.
Mark D Vincent

Bioessays· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer.
Tristan A Barnes, Grainne M O'Kane, Mark David Vincent, Natasha B Leighl

Front Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancer.
Mark D Vincent, Daniel Breadner, Denis Soulieres, Ian G Kerr, Michael Sanatani

Future Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment Serum Folate Levels and Toxicity/Efficacy in Colorectal Cancer Patients Treated With 5-Fluorouracil and Folinic Acid.
Michael Yan, Cheryl Ho, Eric Winquist, Derek Jonker, Daniel Rayson, Mark D Vincent

Clin Colorectal Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine.
Christine Di Cresce, Rene Figueredo, Mateusz Rytelewski, Saman Maleki Vareki, Colin Way, Mark D Vincent

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promising targets and current clinical trials in metastatic squamous cell lung cancer.
Mark D Vincent

Front Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cancer's weaknesses (not its strengths): Therapeutic strategies suggested by the atavistic model.
Charles H Lineweaver, Paul C W Davies, Mark D Vincent

Bioessays· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS.
Grzegorz J Korpanty, Donna M Graham, Mark D Vincent, Natasha B Leighl

Front Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.
Nicholas P Campbell, Rangesh Kunnavakkam, Natasha Leighl, Mark D Vincent, David R Gandara

Lung Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer: beyond speciation.
Mark D Vincent

Adv Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis